The Hellenic Journal of Nuclear Medicine, published by the Hellenic Society of Nuclear Medicine, serves as a pivotal platform for researchers, professionals, and students in the fields of nuclear medicine, radiology, and imaging. Based in Greece and established as a prominent forum since 2004, this journal is dedicated to advancing the understanding and application of nuclear medicine through high-quality original research, reviews, and clinical studies. With an ISSN of 1108-1430 and an E-ISSN of 1790-5427, it has garnered attention within its community, holding a Q3 ranking in the 2023 category of Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging. Despite its current Scopus ranking of #235/333 in the respective fields, the journal is increasingly recognized for its potential to contribute impactful knowledge and innovations. Researchers are encouraged to utilize its resources to enhance their work and contribute to the growing body of knowledge in nuclear medicine. Notably, the journal maintains a commitment to accessible scholarly communication, fostering collaboration among experts across the globe.

NUCLEAR MEDICINE AND BIOLOGY, published by Elsevier Science Inc, is a premier journal dedicated to advancing the fields of nuclear medicine and molecular biology. Since its inception in 1986, this journal has served as a vital platform for the dissemination of high-quality research, with a clear focus on the innovative applications of nuclear techniques in biological settings. It is categorized in the Q3 tier for both Cancer Research and Molecular Medicine, and Q2 for Radiology, Nuclear Medicine and Imaging, highlighting its significant standing within these disciplines. The journal's Scopus rankings reflect its strong impact, placing it in the top quartile of its categories, particularly in Radiology, Nuclear Medicine, and Imaging. Researchers, professionals, and students alike will find this an invaluable resource for contemporary research findings and methodologies in nuclear medicine and its biological applications. Access to the journal is provided through subscription, ensuring that quality content remains available to its wide-ranging audience.

NUCLEAR MEDICINE COMMUNICATIONS is a prestigious academic journal published by Lippincott Williams & Wilkins, focusing on the multifaceted field of nuclear medicine and its applications in diagnostics and therapy. With a solid history spanning from 1980 to 2024, this journal provides a platform for peer-reviewed research articles, clinical studies, and innovative techniques that enrich the knowledge base within the fields of {{medicinal applications, patient care, and imaging technology}}. Currently classified in the Q3 quartile for both Medicine (Miscellaneous) and Radiology, Nuclear Medicine, and Imaging, the journal reflects its commitment to advancing healthcare practices. Although it does not offer open access options, its accessibility through reputable institutions promotes scholarly exchange among researchers, professionals, and students alike. The critical insights provided in NUCLEAR MEDICINE COMMUNICATIONS are essential for those dedicated to enhancing patient outcomes through cutting-edge nuclear medical technologies.

EJNMMI Research, a prominent journal published by Springer, plays a pivotal role in advancing the fields of radiology, nuclear medicine, and imaging. With an impact factor that reflects its strong standing—ranking in the top 22% of its category (Q1 as of 2023)—this open-access journal offers researchers, professionals, and students unparalleled access to innovative research and developments in the field since its inception in 2011. Based in Germany, EJNMMI Research fosters global collaboration by ensuring that cutting-edge findings are freely accessible, thereby accelerating scientific discovery and application. With an emphasis on high-quality, peer-reviewed articles, it serves as an essential resource for those seeking to stay at the forefront of nuclear medicine and imaging. By bridging theoretical insights with practical applications, the journal not only influences academic discourse but also supports ongoing advancements in clinical practices.

Welcome to Seminars in Nuclear Medicine, a prestigious journal published by W B Saunders Co-Elsevier Inc that has been at the forefront of the field since its inception in 1971. This journal serves as a dedicated forum for researchers, healthcare professionals, and students specializing in the rapidly evolving areas of radiology and nuclear medicine. With an impressive ranking of #29 out of 333 in the Scopus category, drawing an esteemed 91st percentile, it holds a distinguished Q1 category status, highlighting its critical role in disseminating high-quality research and clinical practices. Although it does not operate as an Open Access publication, Seminars in Nuclear Medicine remains a vital resource, featuring comprehensive reviews and insightful articles that inform the medical community about the latest advancements and applications within nuclear imaging. This journal not only enhances knowledge but also encourages collaboration among professionals dedicated to improving patient outcomes through innovative nuclear medicine techniques.

Hong Kong Journal of Radiology, an esteemed publication of the Hong Kong Academy of Medicine Press, serves as a vital platform for disseminating innovative research in the field of radiology, nuclear medicine, and imaging. Established in 2011 and operating under an Open Access model since 2018, this journal not only promotes the sharing of knowledge but also enhances global accessibility to cutting-edge studies. With its ISSN 2223-6619 and E-ISSN 2307-4620, the journal strives to engage a diverse audience ranging from experienced professionals to aspiring scholars in the medical imaging domain. Despite its current ranking in the Q4 quartile of the Scopus category for radiology, the journal is committed to improving its standing by featuring high-quality research that addresses pressing issues in the field. The journal's convergence from 2011 to 2024 reflects its ongoing dedication to fostering academic excellence and encouraging collaborative discourse among researchers and practitioners globally. Located in Hong Kong, the journal plays a significant role in shaping the future of radiology education and practice in China and beyond.

NUKLEARMEDIZIN-NUCLEAR MEDICINE is a prestigious journal published by Georg Thieme Verlag KG, focusing on pivotal advancements in the fields of Nuclear Medicine, Radiology, and Imaging. Established in 1959, this journal has served as a critical platform for disseminating innovative research, reviews, and clinical guidelines until its anticipated convergence in 2024. With an ISSN of 0029-5566 and an E-ISSN of 2567-6407, NUKLEARMEDIZIN is acknowledged in the academic community as a Q3 category journal within Medicine (miscellaneous) and Radiology, Nuclear Medicine, and Imaging as of 2023, highlighting its ongoing contribution to the interdisciplinary dialogue in healthcare. Although the journal does not currently offer open access, it remains accessible to professionals and students through various academic databases, ensuring that cutting-edge knowledge in this growing field is shared widely. Researchers interested in the latest methods and technologies in Nuclear Medicine will find NUKLEARMEDIZIN a valuable resource for enhancing their work and understanding the complexities of modern imaging modalities.

The Journal of X-Ray Science and Technology, published by IOS PRESS, serves as a premier platform for researchers and professionals dedicated to advancements in the fields related to X-ray science, imaging techniques, and instrumentation. With an ISSN of 0895-3996 and an E-ISSN of 1095-9114, this journal has established itself as a vital resource since its inception in 1989. The journal has transitioned through multiple publishing phases, currently converging its years of publication from 2001 to 2024, thereby enriching the scientific community’s understanding across various categories, notably in the second quartile (Q2) of Condensed Matter Physics, Electrical and Electronic Engineering, Instrumentation, Radiation, and Radiology, Nuclear Medicine and Imaging as of 2023.

In addition to its commendable Scopus rankings—which highlight its relevance and impact within the medical and physical sciences—the journal emphasizes the dissemination of impactful research, innovative techniques, and collaborative efforts within the X-ray scientific community. Despite being a subscription-based journal, its contributions are crucial for those aiming to stay at the forefront of research and technological development in these rapidly evolving fields.

The Egyptian Journal of Radiology and Nuclear Medicine, published by Springer, is a premier open access journal that has provided valuable insights and advancements in the fields of radiology and nuclear medicine since its initiation in 2010. With an E-ISSN of 2090-4762, this journal is dedicated to bridging the gap between research and clinical practice, allowing for the dissemination of high-quality research to a global audience. Situated in Germany, it enjoys a robust reputation in the academic community, evidenced by its categorization in the Q3 quartile for 2023, as well as its Scopus ranking, where it holds a position of #225 out of 333 in the domain of Radiology, Nuclear Medicine and Imaging, placing it in the 32nd percentile. The journal's open access model ensures that researchers, professionals, and students can freely access innovative studies, reviews, and case reports that discuss the latest methodologies, technological advancements, and clinical outcomes in radiology and nuclear medicine. As it looks toward its converged years spanning from 2010 to 2024, the Egyptian Journal of Radiology and Nuclear Medicine continues to be an essential resource for advancing knowledge and fostering ongoing collaboration in these critical fields.

Revista Española de Medicina Nuclear e Imagen Molecular, published by Elsevier España SLU, stands as a vital resource in the field of Radiology, Nuclear Medicine, and Molecular Imaging. With an ISSN of 2253-654X, this journal is committed to disseminating high-quality research and advancements in clinical practices, aiming to bridge the gap between theoretical research and application in healthcare. Operating since 2012, it features a robust archive of peer-reviewed articles and case studies, although it currently holds a Q4 ranking in the Scopus category, indicating significant potential for growth and influence within the academic community. The journal is indexed in Scopus, with a rank of 255 out of 333, placing it in the 23rd percentile, which underlines the need for increased contributions from researchers eager to enhance its standing. While it is not an open-access journal, its availability through libraries and institutions ensures that a wide audience can access critical findings and innovations in the rapidly evolving field of nuclear medicine. As we look towards the convergence period from 2012 to 2024, Revista Española de Medicina Nuclear e Imagen Molecular aspires to fortify its role as a cornerstone for collaboration and advancement in nuclear imaging and radiology.